Form 8-K - Current report:
SEC Accession No. 0001193125-23-053823
Filing Date
2023-02-28
Accepted
2023-02-28 16:07:13
Documents
14
Period of Report
2023-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d467053d8k.htm   iXBRL 8-K 26629
2 EX-99.1 d467053dex991.htm EX-99.1 140291
6 GRAPHIC g467053g0228125543532.jpg GRAPHIC 2395
  Complete submission text file 0001193125-23-053823.txt   309434

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cers-20230228.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cers-20230228_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cers-20230228_pre.xml EX-101.PRE 11257
8 EXTRACTED XBRL INSTANCE DOCUMENT d467053d8k_htm.xml XML 3384
Mailing Address 1220 CONCORD AVENUE SUITE 600 CONCORD CA 94520
Business Address 1220 CONCORD AVENUE SUITE 600 CONCORD CA 94520 9252886000
CERUS CORP (Filer) CIK: 0001020214 (see all company filings)

EIN.: 680262011 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21937 | Film No.: 23685183
SIC: 3841 Surgical & Medical Instruments & Apparatus